|
|
|
You can get e-magazine links on WhatsApp. Click here
|
|
|
|
|
|
Research changed how people understand human health
|
|
Friday, 12 June, 2026, 16 : 00 PM [IST]
|
|
Dr Neha Raina
|
The global nutraceutical ingredient market is currently undergoing a fundamental change or development as it evolves from a fringe market of health-focused solutions into an irreplaceable building block for preventative medicine worldwide. The global size of this industry is valued at more than $185 billion and has been growing at a compound annual growth rate (CAGR) exceeding 7% per year and sits at the intersection between the complexities of pharmacology and our daily nutrition and diet. One of the primary forces driving the growth of this market is an aging global population and an increase in illnesses associated with chronic lifestyle habits. There has been a dramatic shift among consumers from only taking vitamins to taking nutraceuticals that have clinically validated efficacy based upon demonstration and research studies, provide exact amounts needed of highly absorbent active compounds that target specific physiological pathways, and are produced in a sustainable manner that does not negatively impact our global ecosystem.
The future of the global nutraceutical ingredients industry as a whole will be defined by the following five key vectors: 1) advanced delivery technologies; 2) deep personalisation resulting from integrated data; 3) expanding the microbiome; 4) rigorous clinical standard practices; 5) environmentally sustainable production.
New Developments in Advancing Bioavailability and Next-Generation Delivery Formats
In the past, many of the premium nutraceutical ingredients were kept from working effectively due to low bioavailability. Some examples of these highly sought after hydrophobic nutrients (curcumin, Coenzyme Q10, and some types of polyphenols) have low systemic distribution and high metabolism rates when taken in their traditional form of powders and tablets.
To overcome these biological barriers, the formulation chemists are using advanced technologies that are often seen in pharmaceutical formulations:
Liposomal and Nano-Encapsulation: These two examples of using advanced delivery systems combine to offer manufacturers a new option to protect sensitive nutrients from degradation by gastroacids (gastric acid). Manufacturers can "encapsulate" active ingredients within nano-lipid or nano-polymer structures, thereby enabling the active molecules to be protected en route to the small intestine and, as a result, increase both absorption rates and the amount of therapeutic dosage.
Self-Emulsifying Drug Delivery Systems (SEDDS): Utilising isotropic mixtures of oils, surfactants, and co-solvents, SEDDS automatically form fine oil-in-water emulsions upon contact with gastrointestinal fluids. This approach dramatically improves the dissolution and absorption profiles of lipophilic fat-soluble vitamins and botanical extracts.
"Consumer "Pill Fatigue" Driving a Major Change in Delivery Formats"
At the same time, there has been a large change in how consumers want to receive their supplements, due to "pill fatigue," and R&D teams are changing functional ingredients for use in experiential and convenient formats such as:
a) Functional beverages, including ready-to-drink (RTD) wellness shots, adaptogenic sodas, and effervescent powders designed to dissolve quickly without changing the taste profile;
b) Targeted confectionery products, such as nutrient-dense gummies, functional chocolate, and fast-dissolving oral strips, using advanced masking technologies to mask the natural bitterness of botanical ingredients.
Hyper-Personalisation: The AI and Biomarker Revolution
Nutrigenomics: Suppliers of ingredients are developing targeting active matter that will interact with genetic profiles to help optimise metabolic pathways based on individual DNA.
Dynamic on demand dosing: Using AI, we will be able to create customised ingredient blending systems that will produce an immediate, variable blend of vitamins, minerals and nootropics, as opposed to just taking a daily multivitamin the same way people take them now.
The Microbiome Frontier: Looking Beyond the Probiotic Era
Research into the gut microbiome has dramatically changed how people understand human health globally, and while probiotics dominated the industry with only a handful of common strains, the future of this market is evolving into a complicated, multi-level biotic ecosystem.
Advanced Prebiotic Fibres
As innovation accelerates in this area, obsessions on precise prebiotic substrates are leading to the emergence of prebiotics that are actively targeting specific species of beneficial native gut bacteria by the use of specialised biotic substrates to provide targeted nourishment to these beneficial yet underutilised strains of gut bacteria.
Novel Probiotics
Live biotherapeutic products are being developed as probiotics consisting of specific, sensitive, non-oxygenated types of organisms that are directly related to a specific health outcome (i.e., Akkermansia muciniphila and metabolic health; Faecalibacterium prausnitzii and chronic inflammatory disease states).
The Emergence of Postbiotics
Postbiotics are quickly becoming one of the most rapidly growing segments of the industry due to their inherent stability and ability to be inert by their nature, thus eliminating the need for strict cold chain storage. Postbiotics allow formulation scientists to incorporate the benefits of gut health into many functional foods, baked goods, and carbonated beverages, none of which could support life due to the required temperatures. While the industry was previously dominated by a few standard probiotic bacterial strains, the future market is expanding into a highly sophisticated, multi-tiered biotic ecosystem.
Key Therapeutic Growth Sectors and Emerging Actives
Therapeutic areas that are currently booming are going to be the 3 major tripartite populations (global aging population, emergence of Covid-19 as a global pandemic, and rapid earning growth through e-commerce) will be targeting other newer products within the supplement space. Consumer demand for broad-based immunity products is being replaced with more focused therapeutic categories based on consumer preferences. Following will be some of the key products/categories being developed by manufacturers which cater to the consumer's desires and needs going forward.
Gut-Brain Axis
Consumers are placing an increased emphasis on mental wellness, cognitive function, and improved sleep. Manufacturers' focus has been directed towards developing ingredients that have an effect on the Gut-Brain Axis. Botanical extracts such as Ashwagandha (withanolides), L-Theanine (the amino-acid found in green tea), and top-tier Saffron extracts (crocins and safranal) have all shown double-digit growth rates over the last few years due in part to their ability to regulate cortisol levels and support neurotransmitter balance, while not causing daytime sleepiness.
Cellular Longevity
As the population around the world continues to age, consumers' emphasis on healthy aging is shifting to a focus on cellular longevity and mitochondrial optimisation. Antioxidants, such as Coenzyme Q10 and Ergothioneine, will penetrate the functional product space very quickly.
Regulatory Aspects and Standardisation
Currently, the nutraceutical ingredient market has experienced a significant shift towards quality. Extensive scrutiny from worldwide regulatory agencies such as US Food & Drug Administration and the European Food Safety Authority has put an increased emphasis on product labels, structure claims, and supply chain contamination. Manufacturers have been increasingly rejecting unstandardised herbal products in favour of quality, branded materials with precise dosages of a specific bioactive marker. This transition protects companies from regulatory enforcement or recoupment of unverified statements, while also creating long-term consumer confidence.
The future of the nutraceutical ingredients industry is marked by a transition from speculative supplementation to precise, evidence-based nutrition science. Over the next decade, the market will reward companies that reject generic commodities in favour of patented, bioavailable, and clinically tested ingredients. By leveraging pharmaceutical-grade delivery systems, embracing the complexity of the microbiome, and committing to absolute supply chain transparency, the ingredient industry will solidify its position as the foundation of global proactive health and preventive medicine.
(The author belongs to Delhi Pharmaceutical Sciences & Research University, New Delhi. She can be reached at nehapharmaceutics@gmail.com)
|
|
|
|
|
|
|
|
|
|